Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学Endometrial Cancer, Pembrolizumab

Ramez Eskander

MD

🏢UC San Diego Moores Cancer Center🌐USA

Professor of Reproductive Medicine

44
h-index
0
Key Papers
0
Key Contributions

👥Biography 个人简介

Ramez Eskander at UC San Diego is a leading gynecologic oncologist whose research has contributed to establishing lenvatinib plus pembrolizumab as a second-line standard for advanced endometrial cancer (Study 309/KEYNOTE-775). He has contributed to multiple pivotal trials establishing immunotherapy in gynecologic cancers and has been a principal investigator in LEAP trials across endometrial and other gynecologic cancers.

Share:

🧪Research Fields 研究领域

endometrial cancer
pembrolizumab endometrial
KEYNOTE-158
lenvatinib plus pembrolizumab
LEAP-001

🎓Key Contributions 主要贡献

Representative Works 代表性著作

📄Data Sources 数据来源

Last updated: 2026-02-01 | All information from publicly available academic sources

关注 Ramez Eskander 的研究动态

Follow Ramez Eskander's research updates

留下邮箱,当我们发布与 Ramez Eskander(UC San Diego Moores Cancer Center)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment